Hormetic triggers for intervention in aging, disease and trauma

American Journal of Pharmacology and Toxicology

Volumn 3, Issue 1, 2008, Pages 4-13

  Sonneborn, Joan Smith ^a  

^a UNIVERSITY OF WYOMING   (United States)

Author keywords

Aging; Diet restriction; Hibernation; Mimetics; Radiation

Indexed keywords

ALAGEBRIUM; ALCOHOL; AMINOGUANIDINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOBESITY AGENT; ANTIOXIDANT; BIGUANIDE DERIVATIVE; CARNOSINE; DELTORPHIN; DNA; ENKEPHALIN[2 ALANINE 5 LEUCINE]; HEAT SHOCK PROTEIN 70; INSULIN; OLIGONUCLEOTIDE; PEPTIDE DERIVATIVE; SOMATOMEDIN C;

AGING; ALZHEIMER DISEASE; ARTERIOSCLEROSIS; ARTICLE; BLEEDING; BLOOD PRESSURE REGULATION; CALORIC RESTRICTION; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CELLULAR IMMUNITY; DIABETES MELLITUS; DIET RESTRICTION; DNA DAMAGE; DNA REPAIR; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; EXERCISE; GENETIC STABILITY; HEART FAILURE; HEART INFARCTION; HEART PROTECTION; HEART RATE; HEAT; HORMESIS; HUMAN; HYPERTENSION; IMMUNOREGULATION; INDUCED HYPOTHERMIA; INFECTION; KIDNEY FAILURE; LONGEVITY; LOW DRUG DOSE; MUSCLE ATROPHY; NEOPLASM; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN CROSS LINKING; PROTEIN FUNCTION; PROTEIN STRUCTURE; STROKE; SURVIVAL RATE; THERAPY EFFECT;

ANURA; CHONDRICHTHYES; MARMOTA MONAX;

EID: 52949125178     PISSN: 15574962     EISSN: 15574970     Source Type: Journal    
DOI: 10.3844/ajptsp.2008.4.13     Document Type: Article

References (67)

1. Seyle, H., 1946. The general adaptation syndrome and the disease of adaptation. J. Clin. Endocrinol., 6: 117-230.
2. Calabrese, E.J., K.A. Bachmann, AJ. Bailer, P.M. et al., 2007. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework: Review. Toxicolol. Applied Pharmacol., 222 (1): 122-128.
3. Smith Sonneborn, J., 1992. Overview lecture. The role of the stress protein response in hormesis. In: Low Dose Irradiation and Biological Defense Mechanisms. Sugahara, T., L.A. Sagan and T. Aoyama, (Eds.). pp: 399-404. Excerpta Medica. Elsevier, Amsterdam.
4. Arumugam, T.V., M. Gleichmann, S.C. Tang and M.P. Mattson, 2006. Hormesis/preconditioning mechanisms, the nervous system and aging: Review. Ageing Res. Rev., 5 (2): 165-178.
5. Morimoto, R.J., 2006. Stress, aging and neurodegenerative disease: Review. The New England J. Medicine, 355 (21): 2254-2255.
6. Pierpaoli, E., 2005. The role of HSP70 in age-related diseases and the prevention of cancer: Review. Ann. of the New York Academy of Sciences, 1057: 206-19.
7. Rattan S.I. and R.E. Ali, 2007. Hormetic prevention of molecular damage during cellular aging of human skin fibroblasts and keratinocytes: Review. Ann. of the New York Academy of Sciences, 1100: 424-430.
8. Singh, R., Kolvraa, S. and S.I. Rattan, 2007. Genetics of human longevity with emphasis on the relevance of HSP70 as candidate genes: Review. Frontiers in Bioscience, 12: 4504-4513.
9. Su, C.Y., K.Y Chong, O.E. Owen, W.H. Dillmann, C. Chang and C.C. Lai, 1998. Constitutive and inducible HSP70s are involved in oxidative resistance evoked by heat shock or ethanol. J. Mol. Cellular Cardiol., 30 (3): 587-98.
10. Belmadani A.S., S. Kumar, M. Schipma, M.A. Collins and E.J. Neafsey, 2004. Inhibition of amyloid-beta-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport, 15 (13): 2093-2096.
11. Wang, Q., A.Y. Sun, A. Simonyi, T.J. Kalogeris, D.K. Miller, G.Y. Sun and R.J. Korthuis, 2007. Ethanol preconditioning protects against ischemia/reperfusion-induced brain damage: Role of NADPH oxidase-derived ROS. Free Radi. Biol. Med., 43 (7): 1048-60.
12. Yamaguchi, T., C. Dayton, T. Shigematsu, P. Carter, T. Yoshikawa, D.C. Gute and R.J. Korthuis, 2002. Preconditioning with ethanol prevents postischemic leukocyte-endothelial cell adhesive interactions. Am. J. Physiol., Heart Circulatory Physiol., 283 (3): H1019.
13. Providencia, R., 2006. Cardiovascular protection from alcoholic drinks: Scientific basis of the french paradox: Review. Portuguese J. Cardiol., 25 (11): 1043-1058.
14. Smith Sonneborn, J. and S. Barbee, 1998. Exercise-induced stress response as an adaptive tolerance strategy. Environ. Health Perspec., 106: 325-330.
15. Sakamoto, M., T. Minamino, H. Toko, Y. Kayama, Y. Zou, M. Sano, E. Takaki, T. Aoyagi, K. Tojo, N. Tajima, N.A. Nakai, H. Aburatani and I. Komuro, 2006. Upregulation of heat shock transcription factor 1 plays a critical role in adaptive cardiac hypertrophy. Circulation Res., 99 (12): 1411-1418.
16. Pollycove, M. and L.E. Feinendegen, 2001. Biologic responses to low doses of ionizing radiation: Detriment versus Hormesis. Part II. Dose responses of organisms. J. Nuclear Med., 42: 26-37.
17. Sonneborn, J. 2005. The myth and reality of reversal of aging by hormesis. Annals of the New York academy of sciences, 1057: 165-176.
18. Sn-dth Sonneborn, J., 1979. DNA Repair and Longevity Assurance in Paramecium tetraurelia. Science, 203: 1115-1117.
19. Hart, R.W. and R.B. Setlow, 1975. DNA repair and life span of mammals, basic life sciences. 5: 80-84.
20. Eller, M.S., T. Maeda, C. Magoni, D. Atwal and B.A. Gilchrest, 1997. Enhancement of DNA repair in human skin cells by thymidine dinucleotide: Evidence for a p53 mediated mammalian SOS response. Proceedings of the National Academy of Sciences of the United States of America, 94: 12627-12632.
21. Arad, S., N. Konnikov, D.A. Goukassian and B.A. Gilchrest, 2007. Quantification of inducible SOS-like photoprotective responses in human skin, 2007. J. Invest. Dermatol., 127 (11): 2629-2636.
22. Arad, S., N. Konnikov, D.A. Goukassian and B.A. Gilchrest, 2006. T-oligos augment UV-induced protective responses in human skin. Federation of Am. Soc. Exp. Biol. J., 20 (11): 1895-1897.
23. Goukassi, D.A., S. Bagheri, L. El-Keeb, M.S. Eller and B.A. Gilchrest, 2002. DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity. Federation of Am. Soc. Exp. Biol. J., 16: 754-756.
24. Goukassian D.A., E. Helms, H. van Steeg, C. van Oostrom, J. Bhawan, B.A. Gilchrest, 2004. Topical DNA oligonucleotide therapy reduces uv-induced mutations and photocarcinogenesis in hairless mice. Proceedings of the National Academy of Sciences of the United States of America, 101 (11): 3933-3938.
25. Aoki, H., E. Iwado, M.S. Eller, Y. Kondo, K. Fujiwara, G.Z. Li, K.R. Hess, D.R. Siwak, R. Sawaya, G.B. Mills, B.A. Gilchrest and S. Kondo, 2007. Telomere 3 overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. Federation of Am. Soc. Exp. Biol. J., 21: 2918-2930.
26. Eller, M.S., X. Liao, S. Liu, K. Hanna, H. Bäckvall, P.L. Opresko, V.A. Bohr and B.A. Gilchrest, 2006. A role for WRN in telomere-based DNA damage responses. Proceedings of the National Academy of Sciences United States of America, 103 (41): 15073-15078.
27. Beani, J.C., 2001. Enhancement of endogenous antioxidant defenses: A promising strategy for prevention of skin cancers, Bulletin de l'Academie Nationale Medecine, 185 (8): 1507-1525.
28. Hamilton, K.L., 2007. Antioxidants and cardioprotection: Review. Med. Sci. in Sports Exer., 39 (9): 1544-1553.
29. Sinclair, D.A., 2005. Toward a unified theory of caloric restriction and longevity regulation: Review. Mechanisms of Ageing and Development, 126: 987-1002.
30. Turturro, A., B.S. Haas and R.W. Hart, 2000. Does caloric restriction induce hormesis? Review. Hum. Exp. Toxicol., 19 (6): 320-329.
31. Roth, G.S., 2005. Caloric restriction mimetics the next phase: Review: Annals of the New York Academy of Sciences, 1057: 365-371.
32. Lane, M.A., G.S. Roth and D.K. Ingram, 2007. Caloric restriction mimetics: A novel approach for biogerontology: Review. Methods in Molecular Biology, 371: 143-9.
33. Anisimov, V.N., 2006. Premature ageing prevention: Limitations and perspectives of pharmacological interventions: Review. Current Drug Targets, 7 (11): 1485-1503.
34. Berstein, L.M., I.G. Popovich, M.A. Zabezhinski, P.A. Egormin, M.L. Tyndyk, I.V. Anikin, A.V. Semenchenko and A.I. Yashin, 2005. Central and peripheral effects of insulin/IGF-1 signaling in aging and cancer: Antidiabetic drugs as geroprotectors and anticarcinogens: Review. Annals of the New York Academy of Sciences, 1057: 220-234.
35. Cefalu, W.T., A.D. Bell-Farrow, Z.Q. Wang, W.E. Sonntag, M.X. Fu, J.W. Baynes and S.R. Thorpe, 1995. Caloric restriction decreases age accumulation of the glycoxidation products, N epsilon-(carboxymethyl) lysine and pentosidine, in rat skin collagen. J. Gerontol. Biol. Sci. Med. Sci., 50 (6): B337-341.
36. Rahbar, S., 2007. Novel inhibitors of glycation and AGE Formation: Review. Cell Biochem. Biophys., 48 (2-3): 147-157.
37. Ulrich, P. and A. Cerami, 2001. Protein glycation, diabetes and aging: Review. Recent Progress in Hormone Res., 56: 1-21.
38. Norton, G.R., G. Candy and A.J. Woodiwiss, 1996. Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats. Circulation, 93: 1905-1912.
39. Hipkiss A.R., J. Michaelis and P.J, Syrris, 1995. Non-Enzymatic glycosylation of the dipeptide L-carnosine, a potential anti-protein-cross-linking agent. Federation of the European Biological Science Letters, 371 (1): 81-85.
40. Boldyrev, A.A., 2005. Protection of proteins from oxidative stress a new illusion or a novel strategy: Review. Annals of the New York Academy of Sciences, 1057: 193-205.
41. Al-Abed, Y., T. Mitsuhashi, H. Li, J.A. Lawson G.A., FitzGerald, H. Founds, T. Donnelly: A. Cerami, P Ulrich and R. Bucala, 1999. Inhibition of advanced glycation endproduct formation by acetaldehyde: Role in the cardioprotective effect of ethanol: Review. Proceedings of the National Academy of Sciences of the United States of America of the United States of Anmeica, 96 (5): 2385-2390.
42. Little, W.C., M.R. Zile, D.W. Kitzman, W.G. Hundley, T.X. O'Brien, R.C. Degroof, 2005. The effect of alagebrium chloride (ALT-711), A novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure. J. Cardiac Failure, 11 (3): 191-195.
43. Susic, D., J. Varagic, J. Ahn and E.D. Frohlich, 2004. Crosslink breakers: A new approach to cardiovascular therapy. Curr. Opin. Cardiol., 19 (4): 336-340.
44. Fujita, M., H. Okuda, O. Tsukamoto, Y. Asano Y. L. Hirata, J. Kim, T. Miyatsuka, S. Takashima, T. Minamino, H. Tomoike and M. Kitakaze, 2006. Blockade of angiotensin II reduces the expression of receptors for advanced glycation end products in human endothelial cells. Arteriosclerosis, Thrombosis and Vascular Biol., 26 (10): 138-142.
45. Lee, I.J., K.S. Jeong, B.J. Roberts, A.T. Kallarakal, P. Fernandez-Salguero, F.J. Gonzalez and B.J. Song, 1996. Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439. Mol. Pharmacol., 49 (6): 980-988.
46. Marchalonis, J.J., S.F. Schulter, R.T. Sepulveda, R.R. Watson and D.F. Larson, 2005. Immunomodulation by immunopeptides and autoantibodies in aging, autoimmunity and infection: Review. Annals of the New York Academy of Sciences, 1057: 247-259.
47. Marchalonis, J.J., S.F. Schulter, R.M. Bernstein, S. Shen and A.B. Edmundson et al., 1998. Phylogenetic emergence and molecular evolution of the immunoglobin family: Review. Advances in Immunology, 70: 417-506
48. Adelman, M.K., S.F. Schulter and J.J. Marchalonis, 2004. The natural antibody repertoire of sharks and humans recognizes the potential universe of antigens. Protein J., 23: 103-118.
49. Yu, Q., R.R. Watson, J.J. Marchalones and D.F. Larson, 2005. A role for T lymphocytes in mediating cardiac diastolic function. Am. J. Physiol., Heart Circulation Physiol., 289: 643-651.
50. Harlow, H.J., T. Lohuis, Y.D. Beck and P.A. Iaizzo. 2001. Muscle strength in overwintering bears. Nature, 409: 997.
51. Lohuis, T.D., H.J. Harlow, T.D. Beck and P.A. Iaizzo, 2007. Hibernating bears conserve muscle strength and maintain fatigue resistance. Physiol. Biochem. Zool., 80 (3): 257-269.
52. Lohuis T.D., H.J. Harlow and T.D. Beck, 2007. Hibernating bears (Ursus Americanus) experience skeletal muscle protein balance during winter anorexia. Comparative Biochemistry and Physiology. Part B Biochemistry and Molecular Biology, 147: 20-28.
53. Horton, N.D., D.J. Kaftani, D.S. Bruce, E.C. Bailey, A.S. Krober, J.R. Joanes, M. Tucker, N. Khattar, Y/P/Su, S.F. Bolling and P.R. Oeltgen, 1998. Isolation and partial characterization of an opioid-like 88 kDa hibernation-related protein. Comparative Biochemistry and Physiology, Part B Biochem. Mol. Biol., 119: 787-805.
54. Hong, J., D. C. Sigg, J. A. Coles Jr., P. R. Oeltgen, H. J. Harlow, C.L. Soule and P.A. Iaizzo, 2005. Hibernation induction trigger reduces hypoxic damage of swine skeletal muscle. Muscle and Nerve, 32 (2): 200-207.
55. Smith Sonneborn, J., H. Gottsch, E. Cubin, P. Oeltgen and P. Thomas, 2004. Alternative strategy for stress tolerance: Opioids. J. Gerontol., 59: 433-440.
56. Sigg, D., J.A. Coles Jr, P.R. Oeltgen and P.A. Iaizzo, 2002: Role of δ-opioid receptor agonists on infarct size reduction in swine. Am. J. Physiol., Heart and Circulatory Physiol., 282: H1953-H1960.
57. Hayashi, T., L.I. Tsao and T.P. Su, 2002. Antiapoptotic and cytotoxic properties of delta opioid peptide [D-A1a(2),D-Leu(5)]enkephalin in PC12 cells, Synapse 43(1): 86-94.
58. Rutten, M.R., M. Govindaswami, P. Oeltgen and J. Smith Sonneborn. 2008. Post treatment with the novel deltorphin -E, a δ2 opioid receptor agonist, increases recovery and survival after severe hemorrhagic shock in behaving rats. Shock, 29: 42-48.
59. Vecchio, L., C. Soldani, M.G. Bottone, M. Malatesta, T.E. Martin, L.I. Rothblum, C. Pellicciari and M. Biggiogera, 2006. DADLE induces a reversible hibernation-like state in hela cells. Histoche. Cell Biol., 125 (1-2): 193-201.
60. Borlongan, C.V., Y. Wang and T.P. Su, 2004. Delta opioid peptide (D-A1a 2, D-Leu 5) enkephalin: Linking hibernation and neuroprotection. Frontiers in Biosci., 9: 3392-3398.
61. Erspamer, V., G.F. Erspamer, C. Severini, R.L. Potenza, D. Barra and G. Miqnoqna, 1993. Pharmacological studies of sapa from phyllomedusa bicolor skin: A drug used by the peruvian matses indians in shamanic hunting practices. Toxicon, 9: 99-111.
62. Husted, T.L., M. Govindaswami, P.R. Oeltgen, S.M. Rudich and A.B. Lentsch, 2005. A delta2-opioid agonist inhibits p38 MAPK and Suppresses activation of murine macrophages. J. Surg. Res., 128 (1): 45-49.
63. McBride, S.M., J. Smith-Sonneborn, P.R. Oeltgen and F. Flynn, 2005. Opioid receptor agonist facilitates mean arterial pressure recovery after hemorrhage in conscious rats. Shock, 23: 264-268.
64. Oeltgen, P.R., M. Govindaswami and D.B. Witzke, 2006. Twenty four hour pretreatment with 6 opioid enhances survival from hemorrhagic academic emergency medicine, 13 (2): 127-133.
65. Musser, J.B., T.B. Bentley, S. Griffith, P. Sharma, J. Karaian and P. Mongan, 2004. Hemorrhagic shock in swine: Nitric oxide and potassium sensitive adenosine triphosphate channel activation, anethesiology, 101: 399-408.
66. Zhao, K.S., 2005. Hemorheologic events in severe shock. Biorheol., 42 (6): 463-477.
67. Starnes, J.W. and R.P. Taylor, 2007. Exercise-induced cardioprotection: Endogenous mechanisms. Med. Sci. Sports Exer. 39 (9): 1537-43.